The White House said Friday it’s adding three drugs for diabetes and lung disease to the self-pay platform TrumpRx, as the administration works to expand the site as part of its push to lower drug prices.
The drugs, from German drugmaker Boehringer Ingelheim, are Jentadueto and Jentadueto XR, for Type 2 diabetes, as well as the COPD drug Striverdi Respimat.
According to the White House, the diabetes drugs list for about $525 but are priced on TrumpRx starting around $55, while the COPD drug is listed at about $35, down from roughly $276.
One of the diabetes drugs, Jentadueto, has a generic version that is typically cheaper. For the other drugs, discount prices listed on GoodRx tend to be higher.
“Those are pretty significant discounts,” said Ben Link, a contributor at 46brooklyn, a nonprofit group that tracks prescription drug prices.
Even for Jentadueto, patients typically pay about $25 to $35 at the
...Keep reading this article on NBC News.
